On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayJun 29, 2012 4:59 pm

Seeking Alpha Article Features International Stem Cell Corp. (ISCO), Touts Stem Cell Technology’s Bright Future

In an article published earlier today featuring key players in the stem cell industry, International Stem Cell Corp. was labeled as being possibly "the most promising" as the company has developed a breakthrough technology that provides pluripotent stem cells without using viable human embryos and without the issues associated with induced pluripotent stem cells or adult stem cells. Based upon unfertilized human eggs, ISCO's technology also allows superior immune-matching capabilities. The idea behind stem cells has in fact been around for a very long time. Ever since the invention of the microscope and the development of cell theory, scientists have…

Continue Reading

FridayJun 29, 2012 4:50 pm

Ohr Pharmaceutical, Inc. (OHRP) Announces $2.91M Financing through Exercised Series H Warrants

Ohr Pharmaceutical today announced that its existing shareholders have exercised 5,299,022 Series H warrants at $0.55 per warrant, resulting in net proceeds of $2.91 million. The company offered shareholders 0.6 replacement warrants for every Series H warrant exercised, resulting in the aggregate issuance of 3,179,410 warrants exercisable at $1.20 for a five-year period; 95 percent of the outstanding Series H warrants were exercised in this transaction. Ohr Pharmaceutical said it plans on using the proceeds for general corporate purposes, as well as to advance the clinical development of its compounds: Squalamine eye drops for the treatment of wet-AMD and neovascular…

Continue Reading

FridayJun 29, 2012 3:41 pm

CytoSorbents Corp. (CTSO) Blood Purification System Data Featured at Western Thoracic Surgical Association

CytoSorbents is a therapeutic device company using blood purification to modulate the immune system, reduce severe inflammation, and prevent or treat organ failure caused by life-threatening illnesses. The company today announced the presentation of data from its research collaboration at the Annual Meeting of the Western Thoracic Surgical Association in Hawaii, being held today. Dr. David Rabkin, assistant professor of Surgery, Division of Cardiothoracic Surgery at the University of Washington Medical Center in Seattle, Wash., will present the potential future use of CytoSorb® blood purification system to protect the viability of organs donated by patients who are officially dead from…

Continue Reading

FridayJun 29, 2012 1:03 pm

FluoroPharma Medical, Inc. (FPMI) Targets #1 Most Wanted

In 1950, the FBI formally announced their Ten Most Wanted list to the world, in an attempt to promote the identification and capture of the most notorious fugitives. If there were a ten most wanted health list, coronary artery disease (CAD), still the world’s #1 killer, would be at the top. Several million people die every year from CAD. In the U.S., it is responsible for approximately one third of all deaths. It’s little wonder that the health industry is gunning for CAD in a big way. However, in spite of huge investments in drugs to fight the disease, it…

Continue Reading

FridayJun 29, 2012 11:10 am

Spare Backup, Inc. (SPBU) Announces Launch of Mobile Security and Backup Services with Second European Financial Services Group

Spare Backup, a leading provider of data backup and security software for smartphones, tablets, and PCs, announced plans to launch its services with a second financial services group in Europe as part of a master service agreement with their largest European distributor. Spare Backup is unaffiliated with any carrier or manufacturer. The launch is expected to occur in the next 30 days and will support the strategy of providing services on a private label. "We are excited to launch our Spare Mobile offerings with a second financial services industry partner as we begin to see some early sales data that…

Continue Reading

FridayJun 29, 2012 8:29 am

Telanetix, Inc. (TNIX) Announces Partnership with GreatAmerica to Bundle AccessLine SIP Trunking with Equipment for Business Phones

Telanetix, a cloud-based provider of next-generation hosted voice services for the business market through its AccessLine branded service, and GreatAmerica Leasing Company announced a partnership that will enable GreatAmerica to bill and collect AccessLine SIP trunking charges bundled with business phone equipment. It is anticipated that the partnership will simplify the process of purchasing business phone services and simultaneously take advantage of cost savings that SIP trunking service provides for businesses. GreatAmerica looks forward to capitalizing on its invoicing expertise by billing AccessLine SIP trunking charges, along with PBX equipment and software, on its invoices. The company is also excited…

Continue Reading

FridayJun 29, 2012 8:25 am

Emmis Communications Corp. (EMMS) Selects TuneIn to Broaden Market Reach

Yesterday, TuneIn announced that it has been selected by Emmis Communications to broaden the reach of its 20 stations to the service’s 30 million monthly active listeners. As part of the agreement, Emmis will gain use of a variety of TuneIn tools, such as free analytics and an ad platform. Emmis stations will also promote TuneIn to their listeners on-air. "One of our key focal points is to connect the highest quality broadcasters with the millions of passionate listeners who look to TuneIn to hear their favorite content and discover great new stations and artists," said John Donham, CEO, TuneIn.…

Continue Reading

FridayJun 29, 2012 8:17 am

GSA Advances Green Power Adoption and Significant Energy Savings through World Energy Solutions, Inc. (XWES)

World Energy Solutions, a prominent energy management services firm, announced that it has assisted the U.S. General Services Administration, Region 2, in the procurement of approximately 300 million kWh of electricity. The procurement includes multiple GSA facilities in New York, in addition to other federal accounts, including the American Red Cross, Bureau of Prisons, United Nations, U.S. Coast Guard, and U.S. Department of Veterans Affairs. In a battery of competitive online auctions on the World Energy Exchange ®, GSA tested several products and terms in a reasonable and transparent manner, accumulating 127 bids from six suppliers throughout the process. The…

Continue Reading

ThursdayJun 28, 2012 4:21 pm

Mass Megawatts Wind Power, Inc. (MMMW) Begins Construction of New Patent-Based Wind System

Mass Megawatts Wind Power today said it has commenced construction of a demonstration, low-cost wind system that utilizes the company's patented wind augmentation technology, the Multi-Axis Turbo (MAT). To further demonstrate its technology’s potential, the company also announced that it will install a wind unit without the new low cost augmenter next to the augmented system to prove the MAT’s ability to lower the cost of producing wind-generated electricity. Mass Megawatts' wind augmentation system was designed to increase by 70 percent the wind velocity directed at the turbine, which the company says subsequently triples the increase in the electrical power…

Continue Reading

ThursdayJun 28, 2012 4:19 pm

Access Pharmaceuticals, Inc. (ACCP) Presents Positive Data of MuGard Phase 4 Clinical Trial at Cancer Symposium

Access Pharmaceuticals today said that Dr. Ron R. Allison of Carolina Radiation Medicine, Greenville, NC, recently presented results from the company’s ongoing MuGard phase 4 clinical trial in oral mucositis at the Multinational Association of Supportive Care in Cancer (MASCC) Conference in NYC, presenting summarized data from 70 cancer patients undergoing chemoradiation therapy for head and neck cancer. Data shows that patients using MuGard experienced statistically significant efficacy in: reduction in mouth and throat pain, a common side effect of chemotherapies; a delay to onset of oral mucositis, a debilitating side effect of some radiation and chemotherapy cancer treatments; and…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered